- Conditions
- Coccidioidomycosis
- Interventions
- Spherule-derived coccidioidin
- Biological
- Lead sponsor
- Nielsen BioSciences, Inc.
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 113 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2005 – 2007
- U.S. locations
- 4
- States / cities
- Tucson, Arizona • Bakersfield, California • Blair, Nebraska + 1 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–48
of 24
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Amebiasis, Cryptosporidiosis, Giardiasis, Parasitic Disease, Parasitic Intestinal Disease, Gastrointestinal Helminth Infections
- Interventions
- Not listed
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 3 Years and older
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1977 – 2017
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- Coccidioidomycosis, Pneumonia
- Interventions
- Not listed
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 14 Years to 99 Years
- Enrollment
- 651 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2023
- U.S. locations
- 6
- States / cities
- Phoenix, Arizona • Tucson, Arizona • Bakersfield, California + 2 more
- Conditions
- Coccidioidomycosis
- Interventions
- Not listed
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 2 Years to 100 Years
- Enrollment
- 400 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2029
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- Toxoplasmosis, Cerebral, HIV Infections
- Interventions
- Atovaquone
- Drug
- Lead sponsor
- Glaxo Wellcome
- Industry
- Eligibility
- 13 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- U.S. locations
- 18
- States / cities
- Los Angeles, California • Oakland, California • San Francisco, California + 10 more
- Conditions
- Rift Valley Fever
- Interventions
- IDB-011 dose level 1, IDB-011 dose level 2, IDB-011 dose level 3, IDB-011 dose level 4, IDB-011 dose level 5, Placebo
- Drug · Other
- Lead sponsor
- IDBiologics, Inc.
- Industry
- Eligibility
- 18 Years to 64 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Cypress, California
- Conditions
- Rift Valley Fever
- Interventions
- RVF MP-12
- Biological
- Lead sponsor
- U.S. Army Medical Research and Development Command
- Federal
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2006 – 2009
- U.S. locations
- 1
- States / cities
- Fort Deterick, Maryland
- Conditions
- Invasive Fungal Infections
- Interventions
- Olorofim
- Drug
- Lead sponsor
- F2G Biotech GmbH
- Industry
- Eligibility
- 16 Years and older
- Enrollment
- 203 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2023
- U.S. locations
- 14
- States / cities
- Bakersfield, California • Sacramento, California • San Diego, California + 11 more
- Conditions
- Meningitis, HIV Infections
- Interventions
- Fluconazole
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 13 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- U.S. locations
- 3
- States / cities
- Tucson, Arizona • San Diego, California • San Antonio, Texas
- Conditions
- Toxoplasmosis, Cerebral, HIV Infections
- Interventions
- Pyrimethamine, Leucovorin calcium, Clindamycin
- Drug
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 13 Years and older
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Ends 1992
- U.S. locations
- 13
- States / cities
- Los Angeles, California • Palo Alto, California • San Diego, California + 8 more
- Conditions
- Toxoplasmosis, Cerebral, HIV Infections
- Interventions
- Pyrimethamine, Leucovorin calcium, Zidovudine
- Drug
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years and older
- Enrollment
- 26 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Ends 1995
- U.S. locations
- 2
- States / cities
- New York, New York • Chapel Hill, North Carolina
- Conditions
- Cryptosporidiosis, HIV Infections
- Interventions
- Letrazuril
- Drug
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 13 Years and older
- Enrollment
- 32 participants
- Healthy volunteers
- Healthy volunteers not accepted
- U.S. locations
- 4
- States / cities
- Los Angeles, California • New York, New York
- Conditions
- Cryptosporidium Infection, Cryptosporidiosis
- Interventions
- Cryptosporidium parvum oocysts (ABO809)
- Biological
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Rift Valley Fever
- Interventions
- RVF Vaccine
- Biological
- Lead sponsor
- U.S. Army Medical Research and Development Command
- Federal
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 500 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2024
- U.S. locations
- 1
- States / cities
- Fort Deterick, Maryland
- Conditions
- Cryptosporidiosis, HIV Infections
- Interventions
- Azithromycin
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- U.S. locations
- 4
- States / cities
- Oakland, California • San Diego, California • New York, New York + 1 more
- Conditions
- Cryptosporidiosis, HIV Infections
- Interventions
- Cryptosporidium Immune Whey Protein Concentrate (Bovine)
- Drug
- Lead sponsor
- Stolle Milk Biologic International
- Industry
- Eligibility
- 12 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Toxoplasmosis, Cerebral, HIV Infections
- Interventions
- Pyrimethamine, Leucovorin calcium
- Drug
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 13 Years and older
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Ends 1994
- U.S. locations
- 24
- States / cities
- Palo Alto, California • Torrance, California • Miami, Florida + 16 more
- Conditions
- Toxoplasmosis, Cerebral, HIV Infections
- Interventions
- Pyrimethamine
- Drug
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 13 Years and older
- Enrollment
- 600 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Ends 1992
- U.S. locations
- 16
- States / cities
- San Francisco, California • Denver, Colorado • New Haven, Connecticut + 11 more
- Conditions
- Cryptosporidiosis, HIV Infections
- Interventions
- Nitazoxanide
- Drug
- Lead sponsor
- Romark Laboratories L.C.
- Industry
- Eligibility
- 3 Years to 65 Years
- Healthy volunteers
- Healthy volunteers not accepted
- U.S. locations
- 1
- States / cities
- Tampa, Florida
- Conditions
- Cryptosporidiosis, HIV Infections
- Interventions
- Paromomycin sulfate
- Drug
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 13 Years and older
- Enrollment
- 68 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Ends 1996
- U.S. locations
- 14
- States / cities
- Los Angeles, California • Miami, Florida • Chicago, Illinois + 7 more
- Conditions
- Invasive Fungal Infections
- Interventions
- SUBA itraconazole, Conventional itraconazole
- Drug
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 19 Years and older
- Enrollment
- 88 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2022
- U.S. locations
- 11
- States / cities
- Birmingham, Alabama • Tucson, Arizona • Sacramento, California + 7 more
- Conditions
- Cryptosporidiosis, HIV Infections
- Interventions
- Cryptosporidium Immune Whey Protein Concentrate (Bovine)
- Drug
- Lead sponsor
- Univax Biologics Inc
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- U.S. locations
- 6
- States / cities
- Los Angeles, California • San Francisco, California • Atlanta, Georgia + 2 more
- Conditions
- Coccidioidomycosis, Valley Fever
- Interventions
- SUBA-itraconazole
- Drug
- Lead sponsor
- George R Thompson
- Other
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 1
- States / cities
- Sacramento, California
- Conditions
- Cryptosporidiosis, HIV Infections
- Interventions
- Nitazoxanide
- Drug
- Lead sponsor
- Romark Laboratories L.C.
- Industry
- Eligibility
- 13 Years and older
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2000
- U.S. locations
- 1
- States / cities
- Tampa, Florida